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Background: The aim of this study is to compare X-ray mammography (MG) and ultrasonography (US) in the
diagnosis of breast diseases in Chinese women.
Methods: We retrospectively analyzed X-ray mammograms of 274 patients with US and surgical/pathological results of
breast diseases diagnosed at The Second Affiliated Hospital of Anhui Medical University (Hefei, China) between March
2011 and November 2014. The MG and US data were compared to surgical records using the results from post-surgical
pathological examinations as the gold standard.
Results: The overall sensitivity, specificity, accuracy, false-positive, false-negative, positive predictive value, and negative
predictive value for the detection of breast cancer were 88.5%, 57.9%, 73.7%, 42.1%, 11.5%, 69.2%, and 82.5%, respectively,
for MG and 95.9%, 66.7%, 81.8%, 33.3%, 4.1%, 75.5%, and 93.8%, respectively, for US. Of the 274 cases, lesion size by MG
agreed with surgery in 133 (48.5%) patients compared with 216 (78.8%) by US (P < 0.01). Lesion location by MG agreed
with surgery in 146 (53.3%) patients compared with 257 (93.8%) by US (P < 0.01). These values were then stratified
according to age, menstrual status, breast density, and breast volume, and the agreement rates of MG with surgery
were lower than that of US (all P < 0.01), except when the lesion size was >5 cm (P > 0.05).
Conclusions: US was better than MG in the preoperative evaluation of breast diseases of Chinese women. These
results suggest that US could be more useful for detecting breast lesions in China, especially for younger women
with dense breasts.
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Breast diseases, both benign and malignant, affect many
women worldwide. To enhance early detection, women
are encouraged to undergo routine screening by mam-
mography (MG) [1]. Breast density represents the pro-
portion of different tissue types within a woman’s breast.
Specifically, breast and connective tissues are denser
than fat, and this difference is apparent by MG. When
breast density is high (that is, when there is a greater
amount of breast and connective tissues compared with
fat), mammograms are more difficult to interpret be-
cause a lesion may be shadowed by the dense tissues.* Correspondence: 178331090@qq.com
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unless otherwise stated.Moreover, research has shown that women with high
breast density are at increased risk of developing breast
cancer [2]. Breast density varies by race, and many
Chinese women have dense- or intermediate mixed-
type breast density [3]. Thus, MG may fail to accur-
ately identify tumors within this population. In some
countries, doctors have begun to implement alternative
methods for women with dense breasts. Such measures
include the use of ultrasonography (US) and magnetic
resonance imaging (MRI) [4,5]. MRI is a useful tool to
assess breast diseases and has been shown to have a
higher sensitivity than MG [4,5]. However, MRI is ex-
pensive and waiting lists are often long, limiting its use
in underdeveloped areas of China. In contrast, US
might be more accurate than MG and is cheaper thanhis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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in women [4,5].
Therefore, the present study aimed to retrospectively
analyze MG and US of 274 patients with surgical pathology-
confirmed breast diseases in the diagnosis of breast diseases
in Chinese women, to compare the diagnosis value of MG
and US, and to establish an optimal modality of breast
diseases in underdeveloped areas of China.
The results of the present study could identify the
limitations of MG in the diagnosis of breast diseases in
Chinese women, especially in those with high-density
and relatively small breasts.
Methods
Patients
Two hundred seventy-four consecutive female patients di-
agnosed with breast diseases and who underwent surgery at
The Second Affiliated Hospital of Anhui Medical University
(Hefei, China) from March 2011 through November 2014
were included in the present study. Inclusion criteria were
as follows: 1) presence of a breast lesion on imagery; 2) the
lesion underwent surgery; 3) underwent preoperative MG
and US before; 4) and lesion was confirmed by postop-
erative pathology. Women were excluded if they had
undergone only MG or US. This retrospective study was
approved by the Institutional Review Board of The
Second Affiliated Hospital of Anhui Medical University.
The need for individual consent was waived by the com-
mittee because of the retrospective nature of the study.
MG and US assessment
MG and US were both performed 2 weeks before surgery.
Mediolateral oblique and craniocaudal digital MG of the
breast were performed using a molybdenum-rhodium
target full-field digital MG system (Senographe 2000D,
General Electric, Pittsburgh, PA, USA). If required, add-
itional MG views were obtained. An automatic exposure
factor was used, and adequate pressure was applied on
the breast. All MG examinations were read by two radi-
ologists who were blinded to the patient’s identity and
medical background. The imaging interpretation was
based on the American College of Radiology (ACR) BI-
RADS (Breast Imaging Reporting and Data System) lexi-
con [6]. Breast lesions were classified into six categories
according to the lesion margin and calcification status:
BI-RADS 0 = unsatisfactory MG, and additional imaging
evaluations are needed; BI-RADS 1 = negative, no ab-
normality on MG; BI-RADS 2 = benign findings, pres-
ence of definite benign lesions without any signs of
malignancy; BI-RADS 3 = probably benign lesions, in-
cluding uncalcified lump with negative palpation and
clear boundary and focal, asymmetric, clustering, round
or dot-like calcifications, and a follow-up in a short time
frame is suggested; BI-RADS 4 = suspicious abnormalitywithout typical signs of malignancy, including palpable,
solid lumps with some clear margins, palpable complex
cysts, palpable abscess, solid mass with irregular shape
and infiltrating margin, and newly emerging clustered,
tiny, polygonal calcifications, and biopsy should be consid-
ered; BI-RADS category 5 = highly suggestive of malig-
nancy and appropriate actions should be taken. The total
breast density was classified into ACR levels 1 to 4 [2]:
level 1, almost entirely fatty; level 2, scattered fibroglandu-
lar densities; level 3, heterogeneously dense; and level 4,
extremely dense. In the present study, density levels 1 to 2
were defined as low density, and levels 3 to 4 were defined
as high density. The volume of the breast was measured
using the formula proposed by Kalbhen et al. [7,8]: breast
volume = π/4 × (W ×H ×C), where W is the breast width,
H is the breast height, and C is the compression thickness
in craniocaudal MG.
US examination was performed using a color Doppler
US device (PHLIPS iu22, Philips, Best, The Netherlands)
with a probe frequency of 10 to 18 Hz. All US examinations
were performed with the patient in the supine position for
the medial parts of the breast and in the contralateral
posterior oblique position with arms raised for the lat-
eral parts of the breast. The US examinations were per-
formed by board-certified radiographers classified by
the ACR BI-RADS US standard.
The location and size of the lesions detected by MG and
US were recorded. Lesion location was classified as
located in the upper outer quadrant of the breast, the
lower outer quadrant, the upper inner quadrant, the lower
inner quadrant, the breast areola region, or the axillary
tail region. Lesion size was classified as ≤2.0 cm, 2.1 to
5.0 cm, or >5.0 cm.
Surgery
All included patients underwent surgery. The location
and size of the lesions were recorded during the surgery
according to the same standard as MG and US. Pathology
results were collected.
Data collection
Data were collected including BI-RADS category, micro-
calcifications, menstrual status, histopathology, lesion size,
breast density, and breast volume. For the purpose of the
present study, BI-RADS MG and US categories 1, 2, and 3
were considered as negative, and categories 4 and 5 were
considered as positive.
Statistical analysis
SPSS 16.0 (SPSS Inc., Chicago, IL, USA) was used for
statistical analysis. The breast cancer sensitivity, specificity,
accuracy, false-positive, false-negative, positive predictive
value, and negative predictive value were calculated.
Histopathological examination was considered as the gold
Table 2 BI-RADS categories in mammography and
ultrasonography
BI-RADS MG US
0 38 (13.9%) 0 (0%)
1 30 (10.9%) 4 (1.5%)
2 7 (2.6%) 32 (11.7%)
3 43 (15.7%) 67 (24.5%)
4 113 (41.2%) 150 (54.7%)
5 43 (15.7%) 21 (7.7%)
Total 274 (100%) 274 (100%)
BI-RADS, Breast Imaging Reporting and Data System; MG, mammography;
US, ultrasonography.

















Others (malignant) 5 (1.8)
Others (benign) 7 (2.6)
Lesion size (cm)
≤2 122 (44.5)









400 to 800 142 (51.8)
>800 12 (4.4)
ACR. American College of Radiology; DCIS, ductal carcinoma in situ; IDC,
invasive ductal carcinoma.
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lesion by histopathology. A true positive was defined as
positive evidence of malignancy on histopathology.
BI-RADS categories of 0 were excluded from sensitivity,
specificity, accuracy, false-positive, false-negative, posi-
tive predictive value, and negative predictive value
analysis but were kept for the analysis of the location
agreement. Lesion size and location were compared
between imaging modalities and surgery.
Results
Characteristics of the patients
Of the 274 patients, 132 were with pathologically proven
malignancy and 142 were benign. Among these patients,
185 (67.5%) were premenopausal and 89 (32.5%) were post-
menopausal. Patients aged from 24 to 80 years, with 129
(47.1%) being ≤45 years old and 145 (52.9%) being >45
years old. The clinical data are shown in Table 1.
Comparison between MG and US assessment
As shown in Table 1, 41 (15.0%) cases were classified as
ACR level 1; 92 (33.6%) were level 2; 127 (46.3%) were
level 3; and 14 (5.1%) were level 4. The average breast
volume of the 274 cases was 419 ± 149 ml (range 91 to
1,130 ml), among whom 120 (43.8%) were ≤400 ml, 142
(51.8%) were 400 to 800 ml, and 12 (4.4%) were >800 ml.
Of the 274 cases, MG BI-RADS category was 0 in 38
(13.9%) cases, category 1 in 30 (10.9%), category 2 in 7
(2.6%), category 3 in 43 (15.7%), category 4 in 113 (41.2%),
and category 5 in 43 (15.7%). US BI-RADS category was 1
in 4 (1.5%) cases, category 2 in 32 (11.7%), category 3 in
67 (24.5%), category 4 in 150 (54.7%), and category 5 in 21
(7.7%) (Table 2).
Comparison of the diagnostic accuracy between MG and
US
The overall sensitivity, specificity, accuracy, false-positive,
false-negative, positive predictive value, and negative
predictive value for the detection of breast cancer were
88.5%, 57.9%, 73.7%, 42.1%, 11.5%, 69.2%, and 82.5%,
respectively, for MG and 95.9%, 66.7%, 81.8%, 33.3%,
4.1%, 75.5%, and 93.8%, respectively, for US. The over-
all values of US were higher than that of MG. These
values were then stratified according to age, menstrual
status, breast density, and breast volume (Table 3).
Subgroups analyses presented in Table 3 also suggest
that sensitivity and accuracy were lower with MG than
with US in women ≤45 years old (sensitivity: 73.7% vs.
89.5%, accuracy: 65.4% vs. 76.0%), premenopausal (sen-
sitivity: 81.0% vs. 91.9%, accuracy: 64.9% vs. 79.7%), or
with high breast density (sensitivity: 63.2% vs. 92.3%,
accuracy: 71.7% vs. 79.7%). We excluded 38 (14%)
patients who were classified as BI-RADS category 0 in
MG because the imaging findings were unsatisfactory
Table 3 Comparison of diagnostic value between MG and US
Method Sensitivity Specificity Accuracy False-positive False-negative Positive PV Negative PV
All MG 88.5% 57.9% 73.7% 42.1% 11.5% 69.2% 82.5%
US 95.9% 66.7% 81.8% 33.3% 4.1% 75.5% 93.8%
Age ≤45 years MG 73.7% 60.6% 65.4% 39.4% 26.3% 51.9% 80.0%
US 89.5% 68.2% 76.0% 31.8% 10.5% 61.8% 91.8%
Age >45 years MG 95.2% 54.2% 80.3% 45.8% 4.8% 78.4% 86.7%
US 98.8% 64.6% 86.4% 35.4% 1.2% 83.0% 96.9%
Premenopausal MG 81.0% 53.8% 64.9% 46.2% 19.0% 54.8% 80.3%
US 91.9% 71.4% 79.7% 28.6% 8.1% 68.7% 92.9%
Postmenopausal MG 96.6% 73.9% 90.2% 26.1% 3.4% 90.5% 89.5%
US 100.0% 47.8% 85.4% 52.2% 0.0% 83.1% 100.0%
Low breast density MG 92.9% 52.1% 76.3% 47.9% 7.1% 73.9% 83.3%
US 98.6% 62.5% 83.9% 37.5% 1.4% 79.3% 96.8%
High breast density MG 63.2% 82.7% 71.7% 17.3% 36.8% 82.7% 63.2%
US 92.3% 69.7% 79.7% 30.3% 7.7% 70.6% 92.0%
MG, mammography; PV, predictive value; US, ultrasonography.
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sive ductal carcinoma (IDC). Thirty (10.9%) cases with
MG BI-RADS category 1 underwent surgery because
of the presence of an obvious mass by US or clinical
examination. Among these 30 patients, histopathology
results revealed the presence of 9 cancers and 21
benign lesions. Figure 1 shows a typical example of the
missed diagnosis of breast disease by MG.
Comparison of agreement rate with surgery between MG
and US
Of the 274 cases, lesion size by MG agreed with surgery
in 131 (47.8%) patients compared with 217 (79.2%) by
US. Of the 274 cases, lesion location by MG agreed with
surgery in 128 (46.7%) patients compared with 250
(91.2%) by US. These values were then stratified accord-
ing to age, menstrual status, breast density, and breast
volume (Table 4), and the agreement rates of MG withFigure 1 MG, US, and post-surgical pathology results from a 43-year-old pati
oblique views of the molybdenum target MG of the right breast. MG were un
(B) MG of the left breast of the same patient. (C) US detected an irregular hyp
revealed an invasive ductal carcinoma (HE staining, ×100). This is a typicalsurgery were lower than that of US (all P < 0.01), except
when the lesion size was >5 cm (P > 0.05) (Table 4). As
shown in Figures 2 and 3, MG often failed to identify
the size and location of the lesion due to dense glands
and overlapping structures.
The chi-square test was used for agreement rates for
lesion size and location between MG and US. P values
<0.05 were considered as significant.
Discussion
The aim of the present study was to compare X-ray MG
and US in the diagnosis of breast diseases in Chinese
women. Results showed that the overall sensitivity, specifi-
city, accuracy, false-positive, false-negative. positive predict-
ive value, and negative predictive value were significantly
higher with US than with MG. Subgroups analyses
suggested that sensitivity and accuracy were lower with
MG than with US in women ≤45 years old, premenopausal,ent with a lump in her right breast. (A) Craniocaudal and mediolateral
satisfactory (BI-RADS category 0) because of the dense gland structure.
oechoic lesion with clear boundaries. (D) Intra-operative pathology
example of a missed diagnosis of breast disease by MG.
Table 4 Comparison between MG and US for agreement rates for lesion size and location
Variable Lesion size Lesion location
MG US P value MG US P value
All 131/274 (47.8%) 217/274 (79.2%) <0.001 128/274 (46.7%) 250/274 (91.2%) <0.001
Age ≤45 55/129 (42.6%) 100/129 (77.5%) <0.001 52/129 (40.3%) 116/129 (89.9%) <0.001
Age >45 76/145 (52.4%) 117/145 (80.7%) <0.001 76/145 (52.4%) 134/145 (92.4%) <0.001
Premenopausal 82/185 (44.3%) 144/185 (77.8%) <0.001 81/185 (43.8%) 167/185 (90.3%) <0.001
Postmenopausal 49/89 (55.1%) 73/89 (82%) <0.001 47/89 (52.8%) 83/89 (93.3%) <0.001
Low breast density 74/133 (55.6%) 109/133 (82.0%) <0.001 67/133 (50.4%) 123/133 (92.5%) <0.001
High breast density 57/141 (40.4%) 108/141 (76.6%) <0.001 61/141 (43.3%) 127/141 (90.1%) <0.001
Lesion <2 cm 46/122 (37.7%) 102/122 (83.6%) <0.001 43/122 (35.2%) 111/122 (91.0%) <0.001
Lesion 2.1 to 5 cm 79/135 (58.5%) 108/135 (80.0%) <0.001 74/135 (54.8%) 123/135 (91.1%) <0.001
Lesion >5 cm 6/17 (35.3%) 7/17 (41.2%) 0.724 11/17 (64.7%) 16/17 (94.1%) 0.09
MG, mammography; US, ultrasonography.
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data, the agreement rates for lesion size and location of
MG were lower than that of US (all P < 0.01), except
when the lesion size was >5 cm (P > 0.05). These results
suggest that US could be a better breast imaging modal-
ity for Chinese women.
Assessment of breast diseases with imaging modalities
such as MG and US provides a mean for lesion detection
and diagnosis. In western countries, MG is the primary
breast cancer screening tool and has demonstrated evi-
dences of reduction of breast cancer mortality [9-11].
However, compared with women from western coun-
tries, Chinese women have their unique characteristics
such as high breast density and small breast volume that
influence the sensitivity and accuracy of MG in detecting
breast diseases [12]. Breast density is negatively associ-
ated with MG sensitivity [13], as well as with mortality
from breast cancer [14]. Indeed, the intrinsic limitations
of MG result in failure to detect 10% to 15% of breast
cancers, and MG sensitivity is reduced particularly in
women with dense breast tissue [1], as shown in the
present study. These data suggest that MG might not beFigure 2 MG, US, and post-surgical pathology results from a 46-year-old pati
identify the location of the lesions. (B) MG of the right breast of the same pat
pathological examination revealed adenosis of the left breast complicated by
misdiagnosed lesion sites by MG compared with pathological examination.an optimal choice for detecting breast lesions in Chinese
women [15,16], which is supported by a study performed
in American women with dense breasts [17,18].
In the present study, all patients were from the Anhui
Province, which is an undeveloped province in the middle
of China, and most of these patients had dense breast
tissue and small breast volume. Of the 274 cases, 38
(13.9%) were classified as BI-RADS category 0, meaning
that an important proportion of women undergoing MG
could not be satisfactorily assessed, which is supported by
previous studies [19,20]. In addition, 30 (10.9%) patients
assessed as being BI-RADS category 1 by MG had a palp-
able mass by clinical examination or had an obvious mass
by US, prompting surgery. Among these 30 patients, nine
were diagnosed with cancer. Therefore, these results
suggest that even MG BI-RADS category 1 was not accur-
ate enough and may miss some malignant lesions.
In the present study, MG had significantly lower sensi-
tivity, specificity, accuracy, false-positive, false-negative,
positive predictive value, and negative predictive value
than US. Stratified analysis showed that young age,
premenopausal, and high breast density decreased theent with a lump in her left breast. (A) MG of the left breast could not
ient. (C) US showed an oval mass in her left breast. (D) Post-surgical
fibroadenoma (HE staining, ×100). This represents a typical example of
Figure 3 MG, US, and post-surgical pathology results from a 38-year-old patient with a lump in her left breast. (A) Craniocaudal and mediolateral
oblique MG of the left breast displayed lesions in the left outer breast, with multiple clusters of microcalcifications, unclear lesion boundaries
(white arrows), and unknown lesion sizes. (B) MG of the right breast of the same patient. (C) The size of lesion was 3 cm by US. (D) Post-surgical
pathological examination revealed adenosis of the breast complicated by fibroadenoma, with focal calcifications (HE staining, ×100). This represents a
typical example of the inability of MG to correctly determine the lesion boundaries and size compared with pathological examination.
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interfere with the interpretation of MG [5,20-23].
In addition, MG could not exactly determine the size and
location of the breast lesion in many cases. This method
only achieved a low agreement rate with surgery for detect-
ing the lesion size and location. A potential reason is that
the surrounding tissues and the lesions have similar X-ray
attenuation, covering the shape and size of the mass. There-
fore, some small cancers may be missed, and some benign
lesions may be subjected to an unnecessary surgery. Never-
theless, MG showed good sensitivity for large palpable
lesions, but these lesions would undergo surgery anyway.
Compared with MG, dense breast tissues are hypere-
choic on US and most lesions are hypoechoic [24,25].
Therefore, because US are not affected by high density
breast tissues, breast US has a higher sensitivity for detect-
ing breast cancers in women with dense breast tissue
[26-28]. Therefore, since Chinese women often have dense
breasts, US should be more effective, accurate, and useful
as the breast imaging tools. In addition, women are not
exposed to radiations.
In the present study, the results strongly suggest that
US was significantly better than MG for detecting breast
diseases. There was no BI-RADS category 0 case reported
by US. In young women and women with dense breasts,
US appears superior to MG as an effective diagnostic tool
in the evaluation of breast diseases. US had a significantly
greater diagnostic accuracy than MG. Finally, US had a
high agreement rate with surgery and it could be used to
determine the exact size and location of the breast lesions.
Therefore, US could be a better screening modality than
MG in Chinese women. In addition, it is much cheaper
than other modalities such as MRI, making it the modality
of choice for areas with a poor economic status. MRI’s
sensitivity to invasive cancers is nearly 100% [29-31], and
that it is not influenced by age or gland density degree
[31,32]. However, MRI is not the best imaging modality to
assess microcalcifications detected on MG since MRI is
based on changes in the spin of hydrogen protons andthat microcalcifications contain few of these [33]. In
addition, MRI machines are expensive, as well as the ex-
aminations per se. Nevertheless, US should be compared
with new modalities such as breast tomosynthesis [34,35].
In some centers, MG and US could be used together to
maximize the detection of breast cancer [36]. In young
asymptomatic high-risk women (<50 years old), digital
MG could be used as the primary screening modality, and
US could be performed if necessary [37]. These results
could be generalized to all women with dense breasts, not
only Chinese ones.
The present study is not without limitations. In addition
to its retrospective nature, the sample size was small and
was from a single center. Multicenter studies should be
performed to confirm these results.
Conclusions
In conclusion, US was better than MG in the preopera-
tive evaluation of breast diseases of Chinese women.
These results suggest that US could be more useful for
detecting breast lesions in China.
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